For patients with lung cancer, advancements such as robotic surgery and video-assisted thoracic surgery have dramatically ...

The U.S. FDA has granted fast track designation to treatment with CLD-201, an oncolytic virus, for patients with soft tissue ...

Dr. Jacob Sands discusses the significance of the FDA approval of Datroway for the treatment of patients with locally ...

For patients with bladder cancer undergoing radical cystectomy, or the surgical removal of the bladder, one possible option ...

A resilience program for young people with advanced cancer helped patients cope early on and led to a better quality of life ...

SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status and is in phase 1 trials for ...

As July concludes, new treatments offer advances across kidney and bladder cancer, with breakthroughs in personalized vaccines and non-surgical therapies.

Writing helped me focus on gratitude and healing after my colon cancer diagnosis, transforming the act into a powerful ...

Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood ...

Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr.

The FDA awarded orphan drug designation to VT3989 for mesothelioma, supporting the experimental cancer treatment’s ...

Jaypirca led to better response rates than Imbruvica in some previously treated patients with chronic lymphocytic leukemia or ...